Bill Gates Foundation Funds Ebola Virus Vaccine Research Stopping Next Ebola Pandemic Will Save Millions Of People
Bill Gates Foundation Funds Ebola Vaccine Research.
EBOLA OUTBREAK MAP .COM
Stopping The Next Ebola Pandemic With Ebola Vaccines
Developing strategies for deploying Ebola vaccines to control future outbreaks of Ebola .
The findings are an important contribution to researchers and public health officials understanding of the Ebola vaccine response, which will aid in the ongoing development of strategies for deploying Ebola vaccines to control future outbreaks of Ebola in Africa and areas outside of Africa including the United States and Europe .
Ebola vaccine being used in Congo produces lasting antibody response, study finds
A team member from the Democratic Republic of Congo’s National Institute of Biomedical Research takes a blood sample from a vaccinated man in North Kivu Province.
February 8, 2022
A new study funded by Bill Gates Foundation and by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo that are experiencing outbreaks of the disease. Among the more than 600 study participants, 95.6% demonstrated antibody persistence six months after they received the vaccine.
The study is the first published research examining post–Ebola-vaccination antibody response in the DRC, a nation of nearly 90 million. While long-term analyses of the study cohort continue, the findings will help inform health officials’ approach to vaccine use for outbreak control, the researchers said.
Ebola, one of the world’s deadliest viral diseases, was first identified in 1976 following an outbreak near the Ebola River in the DRC. Since then, outbreaks have occurred intermittently in sub-Saharan Africa, including 12 outbreaks in the DRC, where the disease remains endemic.
The single-dose rVSVΔG-ZEBOV-GP vaccine, officially licensed in 2019 by both the U.S. Food and Drug Administration and the European Medicines Agency, was administered to more than 300,000 individuals in the DRC during outbreaks between 2018 and 2020. Until now, however, studies examining the antibody response of vaccinated Congolese populations were lacking.
METHOD
UCLA researchers and their colleagues from the Democratic Republic of Congo’s National Institute of Biomedical Research studied individuals who received the vaccine during an Ebola outbreak in the DRC’s North Kivu Province. Between August and September 2018, the team worked alongside the DRC Ministry of Health’s Expanded Program for Immunization and the World Health Organization to enroll and vaccinate 608 eligible individuals who were contacts of people infected with Ebola or contacts of those contacts — an approach known as “ring vaccination” — as well as health care and frontline workers in affected or potentially affected areas.
The researchers collected blood samples at the time of vaccination, 21 days later and again after six months. The found that after 21 days, 87.2% of the study participants showed an antibody response. After six months, 95.6% of all participants showed antibody persistence.
IMPACT
The study provides crucial evidence that Ebola antibody response and persistence after rVSVΔG-ZEBOV-GP vaccination is robust in outbreak settings in the DRC. The findings are an important contribution to researchers’ and public health officials’ understanding of the vaccine response, which will aid in the ongoing development of strategies for deploying vaccines to control future outbreaks of Ebola in areas of the DRC and beyond.
JOURNAL
The study is published online today in the peer-reviewed journal Proceedings of the National Academy of Sciences.
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).
Dig a little deeper to learn that these same pigs developed a virulent form of Ebola virus at the Sierra Leone U.S. Army Biowarfare laboratory. Curiously, the lack of precious gems, oil and gold in the ground acts as an antibiotic toward this Rockefeller sponsored strain of Ebola, which does not resemble the old type of Ebola in the least. God says go ahead and burn these lying pigs. He will do the necessary processing. John 14:9. You better believe it.
ARE YOU A COMPLETE MORON?
GATES AND FAUCI ARE ONLY INTERESTED IN GAIN OF FUNCTION RESEARCH TO WEAPONIZE VIRUSES FOR BIOLOGICAL WARFARE